| PERIOD ENDING | 31-Dec-08 | 31-Dec-07 | 31-Dec-06 | | Total Revenue | 4,144,380 | 5,320,151 | 4,179,780 | | Cost of Revenue | 2,772,558 | 3,131,720 | 2,735,947 | | | Gross Profit | 1,371,822 | 2,188,431 | 1,443,834 | | | Operating Expenses | | Research Development |
-
|
-
| 19,014 | | Selling General and Administrative | 267,820 | 435,347 | 250,951 | | Non Recurring | 16,981 | 31,548 | 487 | | Others | 210,465 | 177,142 | 206,725 | | | | Total Operating Expenses |
-
|
-
| 477,177 | | | | Operating Income or Loss | 876,557 | 1,544,393 | 966,657 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (62,871) | 171,598 | (40,549) | | Earnings Before Interest And Taxes | 828,308 | 1,697,940 | 1,024,946 | | Interest Expense | 7,743 | 297,640 | 6,921 | | Income Before Tax | 820,565 | 1,400,301 | 1,018,025 | | Income Tax Expense | 271,674 | 468,165 | 329,802 | | Minority Interest | (4,171) | (2,937) | (83) | | | | Net Income From Continuing Ops | 528,301 | 947,250 | 602,365 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
| (15,267) | | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | 528,301 | 947,250 | 587,098 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $528,301 | $947,250 | $587,098 |
|
0.83% Nasdaq 0.00%
Income Statement
